UB Paderborn / Katalog / Suche / in CDI

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets

Toxins, 2021-02, Vol.13 (2), p.142

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine

Nephrology, dialysis, transplantation, 2016-06, Vol.31 (6), p.937-944

2016

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs

Journal of clinical pharmacology, 2007-05, Vol.47 (5), p.566-578

2007

Link zum Volltext

Verfügbarkeit prüfen

Blood−brain barrier transporters and response to CNS-active drugs

European journal of clinical pharmacology, 2009-11, Vol.65 (11), p.1063-1070

2009

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics for the identification of early biomarkers of nephrotoxicity in a mouse model of cisplatin-induced acute kidney injury

Biomedicine & pharmacotherapy, 2023-07, Vol.163, p.114787-114787, Article 114787

2023

Link zum Volltext

Verfügbarkeit prüfen

Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins

Circulation research, 2010-02, Vol.106 (2), p.297-306

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of CKD and Dialysis Modality on Exposure to Drugs Cleared by Nonrenal Mechanisms

American journal of kidney diseases, 2015-04, Vol.65 (4), p.574-582

2015

Link zum Volltext

Verfügbarkeit prüfen

Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function

Scientific reports, 2019-05, Vol.9 (1), p.6831-6831, Article 6831

2019

Link zum Volltext

Verfügbarkeit prüfen

Mediterranean Diet Score: Associations with Metabolic Products of the Intestinal Microbiome, Carotid Plaque Burden, and Renal Function

Nutrients, 2018-06, Vol.10 (6), p.779

2018

Link zum Volltext

Verfügbarkeit prüfen

Folic Acid for Stroke Prevention: Time to Revisit Vitamin Therapy in Patients With Kidney Disease?

American journal of kidney diseases, 2015-12, Vol.66 (6), p.942-944

2015

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

Pharmacogenetics and genomics, 2008-05, Vol.18 (5), p.439-448

2008

Link zum Volltext

Verfügbarkeit prüfen

Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences

Current neurology and neuroscience reports, 2022-11, Vol.22 (11), p.757-766

2022

Link zum Volltext

Verfügbarkeit prüfen

Protocol for parallel proteomic and metabolomic analysis of mouse intervertebral disc tissues

JOR-spine, 2020-09, Vol.3 (3), p.e1099-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Metabolic products of the intestinal microbiome and extremes of atherosclerosis

Atherosclerosis, 2018-06, Vol.273, p.91-97

2018

Link zum Volltext

Verfügbarkeit prüfen

Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences

Current neurology and neuroscience reports, 2022-11, Vol.22 (11), p.757-766

2022

Link zum Volltext

Verfügbarkeit prüfen

Reinstalling Antitumor Immunity by Inhibiting Tumor-Derived Immunosuppressive Molecule IDO through RNA Interference

Journal of Immunology, 2006-10, Vol.177 (8), p.5639-5646

2006

Link zum Volltext

Verfügbarkeit prüfen

Propofol neuroprotection in Cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks

Anesthesiology (Philadelphia), 2004-05, Vol.100 (5), p.1151-1159

2004

Link zum Volltext

Verfügbarkeit prüfen

The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs

American journal of physiology: Gastrointestinal and liver physiology, 2010-02, Vol.298 (2), p.G248-G254

2010

Link zum Volltext

Verfügbarkeit prüfen

β -Blocker Dialyzability in Maintenance Hemodialysis Patients: A Randomized Clinical Trial

Clinical journal of the American Society of Nephrology, 2018-04, Vol.13 (4), p.604-611

2018

Link zum Volltext

Verfügbarkeit prüfen

The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial

Nephrology, dialysis, transplantation, 2023-09, Vol.38 (10), p.2192-2200

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis

Expert opinion on drug metabolism & toxicology, 2014-08, Vol.10 (8), p.1131-1143

2014

Link zum Volltext

Verfügbarkeit prüfen

Crohn’s Disease Is Associated with Decreased CYP3A4 and P‑Glycoprotein Protein Expression

Molecular pharmaceutics, 2019-09, Vol.16 (9), p.4059-4064

2019

Link zum Volltext

Verfügbarkeit prüfen

Plasmid-based complementation of large deletions in Phaeodactylum tricornutum biosynthetic genes generated by Cas9 editing

Scientific reports, 2020-08, Vol.10 (1), p.13879, Article 13879

2020

Link zum Volltext

Verfügbarkeit prüfen

Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients

British journal of clinical pharmacology, 2023-02

2023

Link zum Volltext

Verfügbarkeit prüfen

Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications

Journal of renal nutrition, 2019-01, Vol.29 (1), p.55-64

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets

Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine

Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs

Blood−brain barrier transporters and response to CNS-active drugs

Metabolomics for the identification of early biomarkers of nephrotoxicity in a mouse model of cisplatin-induced acute kidney injury

Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins

Effect of CKD and Dialysis Modality on Exposure to Drugs Cleared by Nonrenal Mechanisms

Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function

Mediterranean Diet Score: Associations with Metabolic Products of the Intestinal Microbiome, Carotid Plaque Burden, and Renal Function

Folic Acid for Stroke Prevention: Time to Revisit Vitamin Therapy in Patients With Kidney Disease?

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences

Protocol for parallel proteomic and metabolomic analysis of mouse intervertebral disc tissues

Metabolic products of the intestinal microbiome and extremes of atherosclerosis

Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences

Reinstalling Antitumor Immunity by Inhibiting Tumor-Derived Immunosuppressive Molecule IDO through RNA Interference

Propofol neuroprotection in Cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks

The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs

β -Blocker Dialyzability in Maintenance Hemodialysis Patients: A Randomized Clinical Trial

The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial

Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis

Crohn’s Disease Is Associated with Decreased CYP3A4 and P‑Glycoprotein Protein Expression

Plasmid-based complementation of large deletions in Phaeodactylum tricornutum biosynthetic genes generated by Cas9 editing

Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients

Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications

Suchergebnisse filtern